Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG.
Marshall JL. et al, (2025), Nat Commun, 16
Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route.
Peralta Alvarez MP. et al, (2024), Vaccine, 42
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective cohort study and analysis of transcriptomic predictors of response
Drennan P. et al, (2024), The Lancet Microbe
Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients.
Ongarj J. et al, (2024), Tuberculosis (Edinb), 148
Inhaled aerosol viral-vectored vaccines against tuberculosis.
Stylianou E. and Satti I., (2024), Curr Opin Virol, 66
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control.
Wajja A. et al, (2024), Lancet Infect Dis, 24, e78 - e79